{"id":"triptorelin-injection","safety":{"commonSideEffects":[{"rate":"50-80%","effect":"Hot flashes"},{"rate":"10-30%","effect":"Injection site reaction"},{"rate":"10-30%","effect":"Nausea"},{"rate":"5-20%","effect":"Diarrhea"},{"rate":"5-20%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to GnRH receptors in the pituitary gland, triptorelin injection triggers a cascade of downstream effects that ultimately lead to the suppression of gonadotropin secretion, resulting in decreased levels of sex hormones such as testosterone and estrogen. This mechanism is exploited to treat hormone-sensitive cancers and other conditions.","oneSentence":"Triptorelin injection is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a potent agonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:11.237Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer"},{"name":"Prepubertal central precocious puberty"}]},"trialDetails":[{"nctId":"NCT04484818","phase":"PHASE3","title":"Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-03-01","conditions":"Prostate Carcinoma","enrollment":27},{"nctId":"NCT06282588","phase":"PHASE2, PHASE3","title":"Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers","status":"RECRUITING","sponsor":"Cancer Research Antwerp","startDate":"2023-12-13","conditions":"Prostate Cancer","enrollment":493},{"nctId":"NCT07319429","phase":"PHASE2, PHASE3","title":"Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-25","conditions":"Endometrial Cancer, Fertility","enrollment":260},{"nctId":"NCT07142551","phase":"PHASE2","title":"Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-03-09","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":60},{"nctId":"NCT04931342","phase":"PHASE2","title":"A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2021-10-07","conditions":"Ovarian Cancer","enrollment":176},{"nctId":"NCT07455903","phase":"PHASE2","title":"Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT","status":"NOT_YET_RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2026-04","conditions":"Prostate Cancer, Localized Prostate Carcinoma","enrollment":50},{"nctId":"NCT07254429","phase":"PHASE2","title":"COMPASS - COpenhagen MenoPAuSe Study","status":"RECRUITING","sponsor":"Martin Blomberg Jensen","startDate":"2025-10-02","conditions":"Menopausal Osteoporosis, Bone Markers","enrollment":192},{"nctId":"NCT06129539","phase":"PHASE3","title":"A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Debiopharm International SA","startDate":"2024-07-31","conditions":"Central Precocious Puberty","enrollment":56},{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":194},{"nctId":"NCT05896566","phase":"PHASE2","title":"A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2024-01-23","conditions":"Breast Cancer","enrollment":231},{"nctId":"NCT03332797","phase":"PHASE1","title":"A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genentech, Inc.","startDate":"2017-11-24","conditions":"Breast Cancer","enrollment":181},{"nctId":"NCT00066703","phase":"PHASE3","title":"Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2003-11-03","conditions":"Breast Cancer","enrollment":2672},{"nctId":"NCT00066690","phase":"PHASE3","title":"Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2003-12-17","conditions":"Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma","enrollment":3066},{"nctId":"NCT04356664","phase":"PHASE2, PHASE3","title":"Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis","status":"RECRUITING","sponsor":"Hopital Foch","startDate":"2021-03-18","conditions":"Endometriosis, Adenomyosis, Infertility, Female","enrollment":180},{"nctId":"NCT06059118","phase":"PHASE2","title":"Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-10-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT07340619","phase":"PHASE2","title":"Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.","status":"NOT_YET_RECRUITING","sponsor":"UNICANCER","startDate":"2026-05-18","conditions":"Metastatic (Stage IV) Melanoma","enrollment":51},{"nctId":"NCT05746806","phase":"NA","title":"Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-03-29","conditions":"Recurrent Prostate Cancer","enrollment":36},{"nctId":"NCT03809000","phase":"PHASE2","title":"A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"RTOG Foundation, Inc.","startDate":"2019-04-15","conditions":"Prostate Cancer","enrollment":188},{"nctId":"NCT06528210","phase":"PHASE2","title":"Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer","status":"WITHDRAWN","sponsor":"OHSU Knight Cancer Institute","startDate":"2025-04-16","conditions":"High Risk Prostate Carcinoma, Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8","enrollment":""},{"nctId":"NCT06922318","phase":"PHASE2","title":"The COSMYC Trial (COmbined Suppression of MYC)","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2025-08-19","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":50},{"nctId":"NCT03678025","phase":"PHASE3","title":"Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2018-09-24","conditions":"Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8","enrollment":1273},{"nctId":"NCT05590793","phase":"PHASE3","title":"Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate","status":"COMPLETED","sponsor":"Ipsen","startDate":"2022-11-17","conditions":"Advanced Prostate Cancer, Metastatic Prostate Cancer, Locally Advanced Prostate Cancer","enrollment":195},{"nctId":"NCT05458856","phase":"PHASE3","title":"Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate","status":"COMPLETED","sponsor":"Ipsen","startDate":"2022-08-30","conditions":"Prostate Cancer","enrollment":147},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT01673984","phase":"PHASE4","title":"GP Extended Action Triptorelin","status":"TERMINATED","sponsor":"Ipsen","startDate":"2012-08","conditions":"Prostate Cancer","enrollment":27},{"nctId":"NCT05982093","phase":"PHASE2","title":"Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"SOLTI Breast Cancer Research Group","startDate":"2023-02-03","conditions":"Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor","enrollment":48},{"nctId":"NCT00567580","phase":"PHASE3","title":"Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radiation Therapy Oncology Group","startDate":"2008-02","conditions":"Prostate Cancer","enrollment":1792},{"nctId":"NCT06225284","phase":"PHASE2","title":"Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2024-08-22","conditions":"Triple Negative Breast Cancer, Premenopausal Breast Cancer","enrollment":124},{"nctId":"NCT06795178","phase":"PHASE3","title":"Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer","status":"WITHDRAWN","sponsor":"Foresee Pharmaceuticals Co., Ltd.","startDate":"2025-07-01","conditions":"Prostate Cancer","enrollment":""},{"nctId":"NCT06795191","phase":"PHASE3","title":"Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer","status":"WITHDRAWN","sponsor":"Foresee Pharmaceuticals Co., Ltd.","startDate":"2025-06-01","conditions":"Prostate Cancer","enrollment":""},{"nctId":"NCT03944434","phase":"PHASE2","title":"FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Sandro Pitigliani","startDate":"2018-12-27","conditions":"Breast Cancer","enrollment":116},{"nctId":"NCT05029622","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.","status":"COMPLETED","sponsor":"Ipsen","startDate":"2021-08-10","conditions":"Central Precocious Puberty","enrollment":66},{"nctId":"NCT05286554","phase":"PHASE4","title":"Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-03-17","conditions":"Female Infertility","enrollment":75},{"nctId":"NCT04992026","phase":"PHASE2","title":"The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer","status":"COMPLETED","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2021-01-01","conditions":"Prostatectomy, Oligometastatic Prostate Cancer, Abiraterone","enrollment":130},{"nctId":"NCT02685397","phase":"PHASE2, PHASE3","title":"Management of Castration-Resistant Prostate Cancer with Oligometastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2016-10","conditions":"Castration-resistant Prostate Cancer Patients with Oligometastases","enrollment":102},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT06581679","phase":"NA","title":"Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-12-15","conditions":"Adenomyosis","enrollment":184},{"nctId":"NCT04736602","phase":"PHASE3","title":"Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.","status":"COMPLETED","sponsor":"Ipsen","startDate":"2021-03-27","conditions":"Central Precocious Puberty","enrollment":32},{"nctId":"NCT06487143","phase":"PHASE4","title":"Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-07-01","conditions":"Central Precocious Puberty","enrollment":134},{"nctId":"NCT06481696","phase":"NA","title":"Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility","status":"RECRUITING","sponsor":"Andros Day Surgery Clinic","startDate":"2024-06-01","conditions":"Unexplained Infertility","enrollment":90},{"nctId":"NCT02418572","phase":"PHASE3","title":"Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2015-04","conditions":"Infertility, Poor Ovarian Response","enrollment":290},{"nctId":"NCT05802303","phase":"NA","title":"Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation","status":"TERMINATED","sponsor":"Indira IVF Hospital Pvt Ltd","startDate":"2023-07-25","conditions":"Frozen Embryo Transfer, Infertility, Female","enrollment":172},{"nctId":"NCT03899077","phase":"PHASE2","title":"Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP","status":"UNKNOWN","sponsor":"Cancer Research Antwerp","startDate":"2019-04-05","conditions":"Cancer of Prostate","enrollment":202},{"nctId":"NCT05851547","phase":"PHASE2","title":"Dose Escalation For INtraprostatic LEsions","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2023-11-23","conditions":"Prostatic Neoplasms","enrollment":54},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT05781217","phase":"PHASE3","title":"Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624","status":"RECRUITING","sponsor":"Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic","startDate":"2023-03-14","conditions":"Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence","enrollment":534},{"nctId":"NCT05328258","phase":"PHASE3","title":"Use of GnRHa During Chemotherapy for Fertility Protection","status":"RECRUITING","sponsor":"Kenny Rodriguez-Wallberg","startDate":"2023-03-31","conditions":"Breast Cancer Female, Acute Leukemia, Lymphoma","enrollment":500},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT05555017","phase":"PHASE2","title":"Tracer-Guided Surgery for Recurrent Prostate Cancer","status":"UNKNOWN","sponsor":"The Netherlands Cancer Institute","startDate":"2023-02-15","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT05972902","phase":"PHASE3","title":"Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-15","conditions":"IVF","enrollment":387},{"nctId":"NCT05969834","phase":"","title":"HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-03-31","conditions":"Infertility","enrollment":100},{"nctId":"NCT05945407","phase":"NA","title":"Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2016-08-01","conditions":"Endometrial Neoplasms, Endometrial Neoplasm Malignant, Endometrial Neoplasm Malignant Stage I","enrollment":57},{"nctId":"NCT04616729","phase":"PHASE1, PHASE2","title":"DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":30},{"nctId":"NCT04071574","phase":"PHASE1, PHASE2","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","status":"COMPLETED","sponsor":"Lebanese University","startDate":"2018-02-01","conditions":"Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure","enrollment":200},{"nctId":"NCT04869371","phase":"PHASE2","title":"Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer","status":"UNKNOWN","sponsor":"Hongqian Guo","startDate":"2018-12-12","conditions":"Neoadjuvant Therapy \\ High Risk Prostate Cancer \\ Docetaxel","enrollment":75},{"nctId":"NCT03940807","phase":"PHASE3","title":"Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis","status":"WITHDRAWN","sponsor":"University Hospital, Toulouse","startDate":"2022-04-29","conditions":"Adenomyosis","enrollment":""},{"nctId":"NCT03349905","phase":"NA","title":"Deferred Versus Fresh Embryo Transfers","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-09-24","conditions":"Infertility, Female","enrollment":237},{"nctId":"NCT00564850","phase":"PHASE3","title":"Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty","status":"COMPLETED","sponsor":"Ipsen","startDate":"2007-10","conditions":"Precocious Puberty","enrollment":37},{"nctId":"NCT02113553","phase":"PHASE2","title":"Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve","status":"TERMINATED","sponsor":"Armando Santoro, MD","startDate":"2013-05","conditions":"Breast Cancer","enrollment":45},{"nctId":"NCT05397795","phase":"PHASE3","title":"COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2022-06-01","conditions":"Infertility","enrollment":160},{"nctId":"NCT05212857","phase":"PHASE2","title":"Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2022-04","conditions":"Prostate Cancer","enrollment":160},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT00725491","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05","conditions":"Controlled Ovarian Stimulation","enrollment":259},{"nctId":"NCT05151016","phase":"EARLY_PHASE1","title":"Long-term Use of Mifepristone in the Treatment of Adenomyosis","status":"UNKNOWN","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2021-12-01","conditions":"Adenomyosis, Mifepristone","enrollment":140},{"nctId":"NCT04846218","phase":"NA","title":"Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2016-12","conditions":"Infertility, Female","enrollment":100},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":200},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT03232281","phase":"PHASE3","title":"Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis","status":"COMPLETED","sponsor":"Ipsen","startDate":"2017-07-28","conditions":"Endometriosis","enrollment":300},{"nctId":"NCT04717752","phase":"NA","title":"A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve","status":"UNKNOWN","sponsor":"Nanjing University","startDate":"2021-01-20","conditions":"Poor Ovarian Response","enrollment":310},{"nctId":"NCT00090844","phase":"PHASE2","title":"Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer","status":"TERMINATED","sponsor":"University of South Florida","startDate":"2004-07","conditions":"Breast Cancer, Hormone Changes, Drug Toxicity","enrollment":49},{"nctId":"NCT03536234","phase":"PHASE2","title":"Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients","status":"UNKNOWN","sponsor":"Immune System Regulation AB","startDate":"2018-09-19","conditions":"HIV-1-infection","enrollment":52},{"nctId":"NCT00124514","phase":"PHASE2","title":"Triptorelin for Ovary Protection in Childhood Onset Lupus","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2003-06","conditions":"Systemic Lupus Erythematosus","enrollment":31},{"nctId":"NCT03291821","phase":"NA","title":"DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2017-12-01","conditions":"Infertility, Female","enrollment":136},{"nctId":"NCT01753297","phase":"PHASE4","title":"A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.","status":"COMPLETED","sponsor":"Ipsen","startDate":"2012-12-11","conditions":"Prostate Cancer","enrollment":226},{"nctId":"NCT03428919","phase":"NA","title":"ICSI Versus Conventional IVF in Non-male Factor Couples","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2018-03-16","conditions":"Infertility","enrollment":1064},{"nctId":"NCT02742675","phase":"PHASE2","title":"Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2015-09","conditions":"Prostate Cancer","enrollment":200},{"nctId":"NCT03115307","phase":"PHASE4","title":"Luteal Phase Support in Insemination Cycles","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2017-01","conditions":"Infertility, Female","enrollment":167},{"nctId":"NCT02856048","phase":"PHASE2, PHASE3","title":"Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-11-23","conditions":"Cancer, Toxicity Due to Chemotherapy, Sarcoma","enrollment":11},{"nctId":"NCT01715129","phase":"PHASE3","title":"Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Ipsen","startDate":"2013-01","conditions":"Prostate Cancer","enrollment":126},{"nctId":"NCT00444639","phase":"PHASE2","title":"Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)","status":"TERMINATED","sponsor":"Ipsen","startDate":"2007-02","conditions":"Prostate Cancer","enrollment":25},{"nctId":"NCT01313273","phase":"PHASE3","title":"Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients","status":"TERMINATED","sponsor":"Ipsen","startDate":"2011-06","conditions":"Prostate Cancer","enrollment":3},{"nctId":"NCT01374087","phase":"PHASE2","title":"Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer","status":"TERMINATED","sponsor":"Ipsen","startDate":"2011-11","conditions":"Prostate Cancer","enrollment":32},{"nctId":"NCT02238366","phase":"","title":"Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer","status":"COMPLETED","sponsor":"Ipsen","startDate":"2013-11","conditions":"Prostate Cancer","enrollment":368},{"nctId":"NCT04008966","phase":"PHASE4","title":"Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-07-20","conditions":"Assisted Reproduction","enrollment":160},{"nctId":"NCT02005887","phase":"PHASE2","title":"TRial on the Endocrine Activity of Neoadjuvant Degarelix","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2014-02","conditions":"Breast Cancer Invasive Nos","enrollment":51},{"nctId":"NCT03954197","phase":"NA","title":"Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients","status":"UNKNOWN","sponsor":"Hôpital Jean Verdier","startDate":"2014-09-09","conditions":"Fertility Preservation, Breast Cancer","enrollment":204},{"nctId":"NCT01257425","phase":"PHASE2","title":"Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg","status":"COMPLETED","sponsor":"Ipsen","startDate":"2010-12","conditions":"Prostate Cancer","enrollment":109},{"nctId":"NCT01020448","phase":"PHASE3","title":"Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer","status":"COMPLETED","sponsor":"Ipsen","startDate":"2009-11","conditions":"Prostate Cancer","enrollment":339},{"nctId":"NCT03809221","phase":"PHASE4","title":"The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2019-02-01","conditions":"Infertility, Female","enrollment":1892},{"nctId":"NCT03784404","phase":"PHASE4","title":"Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-12","conditions":"Ovarian Endometrioma","enrollment":100},{"nctId":"NCT01942369","phase":"","title":"A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months","status":"COMPLETED","sponsor":"Ipsen","startDate":"2013-09-16","conditions":"Deep Infiltrating Endometriosis (DIE)","enrollment":402},{"nctId":"NCT02715232","phase":"PHASE4","title":"Effects of Sex Steroids on the Serotonin System","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2017-02-06","conditions":"Gender Dysphoria","enrollment":92},{"nctId":"NCT03684824","phase":"NA","title":"Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-09","conditions":"Invitro Fertilization","enrollment":100},{"nctId":"NCT02737800","phase":"NA","title":"Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2016-04","conditions":"Endometrioma","enrollment":88},{"nctId":"NCT03397537","phase":"PHASE2","title":"Neoadjuvant Endocrine Therapy in Breast Cancer","status":"COMPLETED","sponsor":"Guangdong Provincial People's Hospital","startDate":"2012-09","conditions":"Highly Endocrine Responsive Operable Breast Cancer","enrollment":46},{"nctId":"NCT02381821","phase":"","title":"Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-01-01","conditions":"Reproductive Techniques, Assisted","enrollment":82},{"nctId":"NCT03353883","phase":"PHASE2, PHASE3","title":"Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?","status":"UNKNOWN","sponsor":"Benha University","startDate":"2017-06-01","conditions":"Infertility, Female","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Androgen Deprivation Therapy","Decapeptyl","Gonapeptyl"],"phase":"phase_3","status":"active","brandName":"Triptorelin Injection","genericName":"Triptorelin Injection","companyName":"Ottawa Hospital Research Institute","companyId":"ottawa-hospital-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triptorelin injection is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a potent agonist. Used for Prostate cancer, Prepubertal central precocious puberty.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}